Original Research
COVID-19
Khalil Ansarin  , Ramin Tolouian, Mohammadreza Ardalan* , Ali Taghizadieh, Mojtaba Varshochi, Soheil Teimouri, Tahere Vaezi, Hamed Valizadeh, Parviz Saleh, Saeid Safiri , Kenneth R. Chapman
Based on a randomized clinical trial, bromhexine is proposed as a potential therapeutic option in COVID-19. A total of 78 patients with similar demographic and disease characteristics were treated with results showing a significant reduction in ICU admissions.
|
Aynur Karadağ Gürel* , Selçuk Gürel
As a result, it suggests that the enriched genes and new pathways emerging as a result of the analysis may help identify the group that responds poorly to treatment and the outcome of the treatment.
|
Gang He* , Mei Liu, Tang cong Chen, Li fen Huang, You qiang Ke
|
S Rehan Ahmad* , Md Zeyaullah* , Abdullah M. AlShahrani, Mohammad Suhail Khan, Adam Dawria, Ali Mohieldin, Haroon Ali, Abdelrhman AG Altijani, Mohammad Shane Alam, Munzila Mehdi, Sabika Akram, Ejaz Rizvi Hussain, Mohammad Amjad Kamal
|
Tejpal Yadav , Hemant Kumar Singh Yadav , Abhay Raizaday , Md Sabir Alam*
|